Guides to an Efficient Search for the Best Evidence

ABSTRACT

As a clinician, the selection of the best treatment options for a patient given her clinical diagnosis can be challenging. Textbooks and the knowledge base acquired during residency and fellowship training may be out of date. The following article outlines how to perform a literature search to survey the available treatment options and ultimately how to look for evidence-based guidelines for management of the clinical problem.

Literature search - evidence-based guidelines - medical search engines

REFERENCES

• 1 Ferenczy A, Mutter G. Endometrial hyperplasia and neoplasia: definition, diagnosis and management principles. In: Sciarra J, ed. Gynecology and Obstetrics [CD-ROM] Philadelphia: JB Lippincott 2000
• 2 Ferenczy A, Gelfand M M. The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia.  Am J Obstet Gynecol . 1989;  160 126-131
• 3 Kurman R J, Kaminski P F, Norris H J. The behavior of endometrial hyperplasia.  Cancer . 1985;  56 403-412
• 4 Kurman R J, Kaminski P F, Norris H J. The behavior of endometrial hyperplasia: a long-term study of “untreated” hyperplasia in 170 patients.  Cancer . 1985;  56 403-412
• 5 Dunton C, Baak J, Palazzo J, van Diest P, McHugh M, Widra E. Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistent cancer.  Am J Obstet Gynecol . 1996;  174 1518-1521
• 6 Wentz W B. Effect of a progestational agent on endometrial hyperplasia and endometrial cancer.  Obstet Gynecol . 1964;  24 370-375
• 7 Moyer D L, de Lignieres B, Driguez P, Pez J-P. Prevention of endometrial hyperplasia by progesterone during long-term estradiol replacement: influence of bleeding pattern and secretory changes.  Fertil Steril . 1993;  59 992-997
• 8 Hickey M, Higham J, Fraser I S. Progestogens versus oestrogens and progestogens for irregular uterine bleeding associated with anovulation (Cochrane Review). In: The Cochrane Library, Issue 3 Oxford: Update Software 2001
• 9 Fraser I S. Treatment of ovulatory and anovulatory dysfunctional uterine bleeding with oral progestogens.  Aust N Z J Obstet Gynaecol . 1990;  30 353-356
• 10 Saarikoski S, Yliskoski M, Penttila I. Sequential use of norethisterone and natural progesterone in pre-menopausal bleeding disorders.  Maturitas . 1990;  12 89-97
• 11 Perez-Medina T, Bajo J, Folgueira G, Haya J, Ortega P. Atypical endometrial hyperplasia treatment with progestogens and gonadotropin-releasing hormone analogues: long-term follow-up.  Gynecol Oncol. 1999;  73 299-304